Mind Medicine (MindMed) Inc. Stock Other OTC
Equities
MMEDF
CA60255C1095
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 612M 836M |
---|---|---|---|---|---|
Net income 2024 * | -94M -128M | Net income 2025 * | -106M -145M | EV / Sales 2024 * | - |
Net cash position 2024 * | 184M 252M | Net cash position 2025 * | 99.5M 136M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.37
x | P/E ratio 2025 * |
-5.81
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.59% |
Latest transcript on Mind Medicine (MindMed) Inc.
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 21-01-13 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 22-05-22 |
Miri Wernli
PSD | President | 71 | 20-02-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 21-09-28 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 22-08-10 |
David Gryska
BRD | Director/Board Member | 68 | 23-06-20 |
1st Jan change | Capi. | |
---|---|---|
+2.08% | 42.75B | |
+47.70% | 41.61B | |
+12.39% | 41.34B | |
-12.36% | 26.59B | |
+8.75% | 25.49B | |
-23.35% | 18.12B | |
+30.90% | 12.24B | |
-1.82% | 11.76B | |
+8.72% | 11B |